Patrick “Alan” Lennon, PhD, FACMG, Completes Term as President of the Cancer Genomics Consortium at the CGC Annual Meeting in Nashville, TN

After serving as President-Elect/Scientific Program Chair for the annual meeting held in Denver, CO in 2017, Alan Lennon, PhD, FACMG took the helm as President of the Cancer Genomics Consortium.  The Cancer Genomics Consortium (CGC) is a non-profit organization formed in 2009 by a group of clinical cytogeneticists, molecular geneticists, and molecular pathologists who are interested in applying whole genome and other genetic technologies to cancer diagnosis and cancer research.  During his presidential term, working groups which Lennon fostered back in 2016 to publish evidence-based reviews on assessing whole genome copy number aberrations and copy neutral loss of heterozygosity as best practice in a variety of cancers saw several works accepted for publication. Over 270 cancer geneticists from 7 countries converged on the annual meeting in Nashville, TN, August 5 – 8. The 2018 Annual Meeting was the largest meeting to date and was supported by the largest corporate sponsorship to date. Lennon’s presidential term culminated at the annual meeting, although he serves two more years on the Board of Directors.